Kyungil H. Park

Busan, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 54 publications

Efficacy and Safety of Combination Therapy With Low Dose of Telmisartan and S-Amlodipine in Patients With Hypertension: A Randomized, Double-Blind, Multicenter, Therapeutic Confirmatory, Phase III Clinical Trial.

Efficacy and Safety of Combination Therapy With Low Dose of Telmisartan and S-Amlodipine in Patients With Hypertension: A Randomized, Double-Blind, Multicenter, Therapeutic Confirmatory, Phase III Clinical Trial.

Journal: Clinical therapeutics

Published: October 23, 2025

Metabolic dysfunction-associated steatotic liver disease and risk of heart failure: a nationwide cohort study.

Metabolic dysfunction-associated steatotic liver disease and risk of heart failure: a nationwide cohort study.

Journal: Heart (British Cardiac Society)

Published: August 30, 2025

Single-Pill Low-Dose Triple Combination Therapy vs Standard-Dose Monotherapy in Patients With Mild-to-Moderate Hypertension.

Single-Pill Low-Dose Triple Combination Therapy vs Standard-Dose Monotherapy in Patients With Mild-to-Moderate Hypertension.

Journal: Journal of the American College of Cardiology

Published: August 04, 2025

Abbreviated dual antiplatelet therapy after percutaneous coronary intervention with ultrathin-strut drug-eluting stents in South Korea: 3-year outcomes of the multicentre, randomised HOST-IDEA trial.

Abbreviated dual antiplatelet therapy after percutaneous coronary intervention with ultrathin-strut drug-eluting stents in South Korea: 3-year outcomes of the multicentre, randomised HOST-IDEA trial.

Journal: EClinicalMedicine

Published: July 24, 2025

A Comparison Study of Olmesartan and Valsartan Effects on Myocardial Metabolism in Patients With Dilated Cardiomyopathy: the OVOID Trial.

A Comparison Study of Olmesartan and Valsartan Effects on Myocardial Metabolism in Patients With Dilated Cardiomyopathy: the OVOID Trial.

Journal: Journal of the American Heart Association

Published: June 27, 2025

Duration of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention for bifurcation lesions: Insights from the ULTRA-BIFURCAT registry.

Duration of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention for bifurcation lesions: Insights from the ULTRA-BIFURCAT registry.

Journal: International journal of cardiology

Published: March 29, 2025

Effectiveness and Safety of Biodegradable Polymer-Coated Everolimus-Eluting Stent in Multivessel Coronary Artery Disease in Routine Clinical Practice: A Korean Multicenter, Prospective, and Observational Study.

Effectiveness and Safety of Biodegradable Polymer-Coated Everolimus-Eluting Stent in Multivessel Coronary Artery Disease in Routine Clinical Practice: A Korean Multicenter, Prospective, and Observational Study.

Journal: Journal of Korean medical science

Published: December 24, 2024

Factors associated with suboptimal adherence to antihypertensive medication: Cross-sectional study using nationally representative databases.

Factors associated with suboptimal adherence to antihypertensive medication: Cross-sectional study using nationally representative databases.

Journal: Heliyon

Published: March 28, 2024

Hemodynamic Changes in Chronic Liver Disease

Hemodynamic Changes in Chronic Liver Disease

Journal: The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi

Published: October 16, 2023

Comparison of 3- to 6-Month Versus 12-Month Dual Antiplatelet Therapy After Coronary Intervention Using the Contemporary Drug-Eluting Stents With Ultrathin Struts: The HOST-IDEA Randomized Clinical Trial.

Comparison of 3- to 6-Month Versus 12-Month Dual Antiplatelet Therapy After Coronary Intervention Using the Contemporary Drug-Eluting Stents With Ultrathin Struts: The HOST-IDEA Randomized Clinical Trial.

Journal: Circulation

Published: March 05, 2023

Comparative effects of nebivolol and carvedilol on left ventricular diastolic function in older patients with heart failure and preserved ejection fraction.

Comparative effects of nebivolol and carvedilol on left ventricular diastolic function in older patients with heart failure and preserved ejection fraction.

Journal: International journal of cardiology. Cardiovascular risk and prevention

Published: February 09, 2023

Comparison of efficacy and safety between third-dose triple and third-dose dual antihypertensive combination therapies in patients with hypertension.

Comparison of efficacy and safety between third-dose triple and third-dose dual antihypertensive combination therapies in patients with hypertension.

Journal: Journal of clinical hypertension (Greenwich, Conn.)

Published: January 18, 2023

Showing 1-12 of 54

Last Updated: 09/26/2026